Webcast: Neuralstem, Inc. at Biotech Showcase 2012 (includes update on ALS trial)

Via Scoop.it – ALS Lou Gehrig’s Disease

The webcast of President and CEO Richard Garr’s presentation at Biotech Showcase in San Francisco is now available, and has been posted on the company’s Investor Center. The January 10th presentation includes updates on Neuralstem’s ongoing ALS and NSI-189/major depressive disorder trials. Registration required to access the webcast.
Via investor.neuralstem.com